Clinical Trials
45 trials99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Nanjing First Hospital, Nanjing Medical University
INSPIRE
Singlera Genomics Inc.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
ONFM-SBRT
Peking University Third Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
MK-3475-E90
Wellmarker Bio
VUBAR
Universitair Ziekenhuis Brussel
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
RESTORE
Blue Note Therapeutics
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
Betta Pharmaceuticals Co., Ltd.
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
MIRACLE
Kyunghee University Medical Center
PIONEER
SpeciCare
OMT-111 for Terminal Stage Solid Tumors
MetiMedi Pharmaceuticals
WATTOX
Royal Marsden NHS Foundation Trust
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
PIPACRegis
University of Magdeburg
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
COTI2-101
Critical Outcome Technologies Inc.
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
M14AFS
The Netherlands Cancer Institute
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
NHS Greater Glasgow and Clyde
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Southwest Hospital, China
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
SPGO Research Mannheim GmbH
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition
The Leeds Teaching Hospitals NHS Trust
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
EGFR; PET/CT
Hadassah Medical Organization
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals